Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引：0
|
作者：
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构：
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3507 / 3512
页数：5
相关论文
共 50 条
  • [1] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [2] Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer
    Renninson, Emily
    Closier, Philippa
    Jonnada, Sai
    CLINICAL ONCOLOGY, 2018, 30 : E1 - E1
  • [3] Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer
    Renninson, Emily
    Closier, Philippa
    Jonnada, Sai
    CLINICAL ONCOLOGY, 2018, 30 : E4 - E4
  • [4] Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
    Advani, S. H.
    Achreckar, Suvarna
    Thomas, Dennis
    Krishnankutty, Binny
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2010, 31 (03) : 79 - 82
  • [5] Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors
    Timmer-Bonte, Johanna N. H.
    Tjan-Heijnen, Vivianne C. G.
    ANTI-CANCER DRUGS, 2006, 17 (08) : 881 - 889
  • [6] Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: A meta-analysis of randomized controlled trials
    Sung, L
    Nathan, PC
    Lange, B
    Beyene, J
    Buchanan, GR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3350 - 3356
  • [7] Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
    Sakurada, Takumi
    Bando, Sanako
    Zamami, Yoshito
    Takechi, Kenshi
    Chuma, Masayuki
    Goda, Mitsuhiro
    Kirino, Yasushi
    Nakamura, Toshimi
    Teraoka, Kazuhiko
    Morimoto, Masami
    Tangoku, Akira
    Ishizawa, Keisuke
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (05) : 1107 - 1114
  • [8] Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
    Takumi Sakurada
    Sanako Bando
    Yoshito Zamami
    Kenshi Takechi
    Masayuki Chuma
    Mitsuhiro Goda
    Yasushi Kirino
    Toshimi Nakamura
    Kazuhiko Teraoka
    Masami Morimoto
    Akira Tangoku
    Keisuke Ishizawa
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1107 - 1114
  • [9] Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer
    Zekri, Jamal
    Nawaz, Azhar
    Rasool, Haleem
    Ahmad, Imran
    Abdel Rahman, Hossam
    Dada, Reyad
    Abdelghany, Ehab Mosaad
    Farag, Kamel
    Ibrahim, Refaei Belal
    Deibas, Mohamed Youssef
    Kamel, Mohamed Kamal
    Allithy, Ahmed
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1681 - 1686
  • [10] Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D
    Lee, Esther K.
    Wong, William W. L.
    Trudeau, Maureen E.
    Chan, Kelvin K. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 169 - 180
12345